We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Innovative Hospital Privacy Curtains Resist Superbug Contamination

By HospiMedica International staff writers
Posted on 13 Nov 2012
Hospital privacy curtains embedded with an experimental antimicrobial technology may play a role in decreasing transmission of healthcare associated pathogens. More...


Researchers at the University of Iowa (Iowa City, USA) conducted a randomized, controlled trial to assess the effectiveness in a clinical setting of curtains incorporating a complex element compound (CEC) with antimicrobial properties. Twenty-one rooms in a surgical intensive care unit (ICU) and 9 rooms in a medical ICU were randomly selected to receive either a new standard curtain or a new identical-looking PurThread Technologies (Princeton, NJ, USA) CEC curtain; in all, 15 rooms received CEC curtains and 15 received standard curtains.

Cultures were performed of samples that were collected from the curtains twice a week for 23 days. Contamination was determined according to standard microbiologic methods, as were time to contamination, and incidence rates of contamination. The results showed that the standard control curtains were eight times more likely to be contaminated with the superbug vancomycin resistant Enterococcus (VRE) than experimental CEC curtains, which only had one positive VRE culture during the entire study.

Additionally, the median time to first contamination of the PurThread curtains took seven times longer than control curtains. On average it took only two days for control curtains to become contaminated with potentially pathogenic bacteria, while PurThread curtains withstood contamination an average of 14 days. The study was published in the November 2012 issue of Infection Control and Hospital Epidemiology.

“The contamination variation, in this study, between PurThread experimental curtains and control curtains shows the antimicrobial materials being developed by PurThread can have a measurable and meaningful impact in a clinical setting,” said Kathryn Bowsher , VP of Clinical and Regulatory Strategy at PurThread Technologies. “This study strengthens our efforts to develop medical textiles that reduce bioburden contamination and contribute to a more hygienic patient environment.”

Studies have shown that 92% of hospital privacy curtains are contaminated with potentially dangerous bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) and VRE within one week of being laundered. Privacy curtains are frequently touched by the freshly washed hands of healthcare workers before touching patients, and they often hang in place for weeks or months without being changed. Bacterial transfer from curtains to healthcare worker gloves is common, and is one of the reasons hands are considered leading vectors of pathogens from staff to patients.

Related Links:
University of Iowa
PurThread Technologies


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.